Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial. - Corless, C L; Ballman, K V; Antonescu, C R (J Clin Oncol, 2014)
, et al.